Results 121 to 130 of about 235,541 (221)

Abstract Supplement HIV Glasgow 8–11 November 2026, Glasgow, UK/Virtual

Journal of the International AIDS Society, Volume 29, Issue S6, November 2026.
wiley   +1 more source

Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study

, 2015
Wai-Ching Lam,1 David A Albiani,2 Pradeepa Yoganathan,3 John Chanchiang Chen,4 Amin Kherani,5 David AL Maberley,6 Alejandro Oliver,7 Theodore Rabinovitch,3 Thomas G Sheidow,8 Eric Tourville,9 Leah A Wittenberg,10 Chris Sigouin,11 Darryl C Baptiste12 ...
Oliver A, Sigouin C, Yoganathan P, Lam WC, Chen JC, Maberley DAL, Rabinovitch T, Albiani DA, Sheidow TG, Kherani A, Wittenberg LA, Baptiste DC, Tourville E   +12 more
core  

Macular pseudohole development after sustained- release dexamethasone intravitreal implant for macular edema due to central retinal vein occlusion.

, 2014
Purpose: To report a case of macular pseudohole (MPH) development after sustained-release dexamethasone intravitreal implant for chronic macular edema due to central retinal vein occlusion (CRVO).
De Nicola C, DI ANTONIO, LUCA, TOTO, LISA, MASTROPASQUA, Leonardo, Mastropasqua A, CARPINETO, Paolo   +5 more
core   +1 more source

DELIVERY OF DRUGS TO THE POSTERIOR EYE SEGMENT USING BIODEGRADABLE MULTILAYER IMPLANT

Офтальмохирургия, 2015
Purpose. To develop a new method of intraocular drug delivery to the posterior segment of the eye using a new biodegradable multilayer sustained-release implant.Material and methods.
Y. A. Belyy, S. V. Novikov, A. V. Tereschenko, A. I. Kolesnik, S. V. Kolesnik   +4 more
doaj  

Management and Complications of Dexamethasone Intravitreal Implant Migration Into the Anterior Chamber. [PDF]

J Vitreoretin Dis, 2022
Betsch DM, Gupta RR.
europepmc   +1 more source

Cost-Effectiveness of Dexamethasone Intravitreal Implant in Naïve and Previously Treated Patients with Diabetic Macular Edema. [PDF]

Int J Environ Res Public Health, 2023
Medina-Baena M, Cejudo-Corbalán O, Labella-Quesada F, Girela-López E.   +3 more
europepmc   +1 more source

Commentary: Dexamethasone intravitreal implant therapy in Vogt-Koyanagi-Harada disease. [PDF]

Indian J Ophthalmol, 2022
Kawali A, Srinivasan S, Mahendradas P, Shetty R.   +3 more
europepmc   +1 more source

Contralateral eye-to-eye comparison of intravitreal ranibizumab and a sustained-release dexamethasone intravitreal implant in recalcitrant diabetic macular edema

, 2016
Benjamin J Thomas, Yoshihiro Yonekawa, Jeremy D Wolfe, Tarek S Hassan Department of Vitreoretinal Surgery, William Beaumont Hospital, Royal Oak, MI, USA Objective: To compare the effects of intravitreal ranibizumab (RZB) or dexamethasone (DEX ...
Yonekawa Y, Wolfe JD, Thomas BJ, Hassan TS   +3 more
core  

Dexamethasone intravitreal implant in diabetic macular oedema refractory to anti-vascular endothelial growth factors: the AUSSIEDEX study. [PDF]

BMJ Open Ophthalmol, 2023
Mitchell P, Arnold J, Fraser-Bell S, Kang HK, Chang AA, Tainton J, Simonyi S.   +6 more
europepmc   +1 more source

Combination of cataract surgery with intravitreal injection of dexamethasone intravitreal implant (Ozurdex) for uveitis-induced cataract. [PDF]

Int J Ophthalmol, 2023
Deng J, Sun WT, Ai H, Wang LP.
europepmc   +1 more source